Imai A, Tsunashima R, Hidaka Y, Kitano S, et al. Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies. Breast Cancer 2025;32:1075-1087.
PMID: 40560329